Study: Cefazolin Better Than Vancomycin for Infection Control in Dialysis Patients
Journal of the American Society of Nephrology suggests cefazolin may be better at controlling infections than vancomycin in dialysis patients.
Researchers compared the effectiveness of various antibiotics at preventing hospitalization and death from bloodstream infection. They reviewed more than 500,000 blood culture results from their chronic kidney disease database, looking for methicillin-sensitive strains of S. aureus bloodstream infection. They also identified when physicians used vancomycin or cefazolin to treat these infections.
The researchers found patients treated with cefazolin experienced a 38 percent lower rate of hospitalization and death from bloodstream infections compared to patients treated with vancomycin. Cefazolin-treated patients also had a 48 percent lower rate of sepsis.
More Articles on Infection Control:
© Copyright ASC COMMUNICATIONS 2012. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.
To receive the latest hospital and health system business and legal news and analysis from Becker's Hospital Review, sign-up for the free Becker's Hospital Review E-weekly by clicking here.
- PriorityOne to Expand Team in 2014, Move to Bigger Office Location
- BayCare Ambulatory Surgery Center to Begin Expansion Project
- Albany Urology Clinic & Surgical Center Opens in New Location
- Greater Miami Chamber of Commerce Names Nueterra Global Alliance Best New Business
- Weill Cornell Researchers Link Controlled Breathing to IBD Symptom Relief